Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03303768
Other study ID # 69HCL17_0477
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2017
Est. completion date August 29, 2018

Study information

Verified date May 2019
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prenatal diagnosis of coarctation is difficult because the ductus arteriosus masks the isthmus narrowing. The problem lies in the fact that it is difficult to assert in utero diagnosis and to predict severity of neonatal symptomatology. However, it is essential to try to establish the diagnosis since it has been shown that the prenatal diagnosis improves survival and reduces morbidity.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date August 29, 2018
Est. primary completion date August 29, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- pregnant or having given birth in the last 12 months in one of the participating centers

- have had an ultrasound screening in the 2nd or 3rd trimester

- addressed or being addressed to the Pluridisciplinary Center for Prenatal Diagnosis for suspected coarctation of isolated aorta in front of: ventricular asymmetry at the aegis of the left ventricle or the large vessels at the aorta, discovered during a screening ultrasound second or third quarter.

- be able to understand and follow the ins and outs of the study

- Have been informed of the study and have not objected to it

Exclusion Criteria:

- Associated complex cardiac disease (transposition of large vessels, atrioventricular duct, right ventricle with double outlet) with the exception of inter ventricular communications

- Left ventricular hypoplasia

- Suspicion of interruption of the aortic arch

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Ultrasound
Investigation of relevant ultrasound signs to improve the antenatal diagnosis of coarctation of the aorta by calculating the sensitivity and specificity of these different signs

Locations

Country Name City State
France Service de Gynécologie Obstétrique Diagnostic Anténatal ; Hôpital Femme Mère enfant Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Search for ultrasound risk factors associated with diagnosis coarctation of the aorta Calculation of sensitivity, specificity and ROC (Receiver Operating Characteristic) curves of the different ultrasound parameters according to post-natal confirma-diagnosis of coarctation of the aorta in order to create a score to improve the antenatal diagnosis of coarctation the aorta. 24h after birth
See also
  Status Clinical Trial Phase
Completed NCT03074773 - The Effect of Paravertebral Block With Dexamethasone on Intraoperative and Postoperative Analgesia in Children Undergoing Surgery for Coarctation of Aorta Phase 1
Recruiting NCT04106479 - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Recruiting NCT04011956 - Prognosis and Integrative Assessment of Aortic Coarctation Patients in China
Recruiting NCT05362721 - PV Loop & Coarctation Study
Recruiting NCT02835703 - Clinical Assessment of Perfusion Techniques During Repair of Coarctation With Aortic Arch Hypoplasia in Infants N/A
Completed NCT00005190 - Reproduction and Survival After Cardiac Defect Repair N/A
Active, not recruiting NCT05405790 - Antibiotic Prophylaxis for TEVAR
Completed NCT05022836 - Four-limb Blood Pressures in Infants With High Risk of Congenital Malformation of Aorta
Completed NCT02545790 - Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions
Recruiting NCT05842876 - Happy Baby Hearts Study
Recruiting NCT06150560 - A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial) Phase 3
Not yet recruiting NCT04288596 - Canadian Adult Congenital Heart Disease Intervention Registry